Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Immunodeficiency Cancer Registry, University of Minnesota, Minneapolis 55455.
It has been estimated that up to 25% of patients with certain genetically determined immunodeficiencies will develop tumors, primarily B-cell lymphomas, during their lifetime. Epstein-Barr virus appears to be an important cofactor in the development of lymphoproliferative disorders in patients with primary immunodeficiencies, as well as acquired immunodeficiencies. Additionally, host defects in immunoregulation and/or gene rearrangement, which are features of certain primary immunodeficiencies, probably contribute to the risk of lymphomagenesis in patients at risk.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on